James E. Bradner

James E. Bradner

Executive Vice President, Research and DevelopmentatAmgen· In proxies 2024–2025

Pay in FY2025-42% from the year before · Amgen stock +25.6% the same year

James E. Bradner was paid $8.6M in FY2025 (Dec), down 42%. Amgen stock rose 25.6% that year.

Pay$100 in the stock at the end of FY23 → $114
Pay is from the Summary Compensation Table of each Amgen proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. AmgenPublic company · 2 yr
    • Executive Vice President, Research and Development2024 – Present · 2 yrStock in role +59%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?